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An increased inflammatory mass in the subarachnoid space during bacterial meningitis
may correlate with a poor outcome of disease. Using a rabbit model of pneumococcal
meningitis, we sought to reduce this inflammatory process. The ability of the pneumo-
coccal cell wall to cause death and to generate leukocytosis and abnormal chemistry in
cerebrospinal fluid was prevented when animals were treated with inhibitors of the cy-
clooxygenase pathway of arachidonate metabolism. Bacterial lysis by ampicillin led to
release of cell wall that caused a significant, transient increase in meningeal inflamma-
tion. This inflammatory burst was also prevented by administering cyclooxygenase inhib--
itors concurrently with the antibiotic.
The morbidity and mortality associated with pneu-
mococcal meningitis is directly proportional to the
amount of inflammation in the subarachnoid space
[1]. Much of the inflammatory response to the pneu-
mococcus arises from the triggering of local host
defenses by the pneumococcal cell surface, particu-
larly the cell wall, which underlies the capsule [2,
3]. Both the complement and the arachidonic acid
pathways generate chemotactic factors in response
to the bacterial cell wall [4]. Because the target of
the ~-lactam family of antibiotics is the bacterial cell
wall, current modes of chemotherapy enhance the
release of cell wall products during bacterial lysisand
killing. Many of these products are highly inflam-
matory when instilled into the CSF space [3]. Al-
though effective bacterial killing can be achieved by
current antibiotic therapy, inflammation may actu-
ally be transiently enhanced as the bacteria lyse. We
explored this possibility by using a rabbit model of
pneumococcal meningitis. Becausecell wall-induced
inflammation involves the generation of chemotac-
tic factors from the arachidonic acid pathway, these
studies were designed to determine if modulation of
antibiotic-induced enhancement of inflammation
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could be achieved by administering nonsteroidal,
anti-inflammatory agents that block the generation
of some arachidonate metabolites. This treatment
regimen may improve the prognosis for patients with
meningitis; morbidity has remained stable at 30070
despite achievement of excellent bactericidal activ-
ity in CSF.
Materials and Methods
Streptococcus pneumoniae strain SIll is a type III
clinical strain from Dr. M. Sande (San Francisco,
Calif). Bacteria were grown in casein hydrolysate
medium at 37 C [2], and midlogarithmic-phase or-
ganisms were harvested, washed in saline, and inocu-
lated into the cisterna magna of rabbits at a concen-
tration of 103 cfu in 0.2 ml of pyrogen-free saline
(Ciba-Geigy, Basel, Switzerland). Bacterial concen-
trations were titrated for cfu on trypticase-soy agar
containing 5% sheep's blood.
Cell walls from unencapsulated S. pneumoniae
strain R6 were prepared by extraction of disrupted
cells with boiling in SDS, digestion with nucleases
and proteases, repeat SDS extraction, and extensive
washing [4]. Lyophilized cell walls were suspended
in pyrogen-free saline (Ciba-Geigy) at a concentra-
tion of 30 J.1g in 0.2 ml, were sonicated briefly, and
were instilled into the cisterna magna of rabbits. This
concentration corresponds to "-'108 whole cellequiva-
lents and is known to cause a brisk inflammatory
response in CSF within 5 hr of challenge [2].
The rabbit model of meningitis was similar to
Dacey and Sande's [5], as described [2, 3]. Male chin-
chilla rabbits weighing 2 kg (Thome Farm, Biebarach
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der Riss, FRG) were tested in groups of four animals
each. Ampicillin (50 mg/kg) was administered iv at
18 hr postinfection by bolus infusion in saline into
an ear vein for 10 min. Table 1 shows the dosing
schedule for animals receivingeither steroids or non-
steroidal anti-inflammatory agents. All medications
were obtained from Ciba-Geigy.
The density of leukocytes in CSF was determined
in serial samples by using a Coulter counter, and the
concentration of protein in CSF was determined by
using the Lowry microdilution method [2]. To de-
termine the concentration of arachidonic acid-path-
way metabolites, we centrifuged samples of CSF
(200 J..I.I) at 10,000 g for 5 min to remove leukocytes,
and the supernatant fluids were frozen at - 70 C for
up to three months before analysis. The samples were
thawed, precipitated in 5 volumes of methanol, cen-
trifuged at 5,000 g for 30 min at 4 C, and dried un-
der argon evaporation. Samples were suspended in
PBS and assayed in duplicate. The presence of leu-
kotriene B4 (LTB4 ) was determined both directly by
bioassay of methanol-extracted supernatants and in-
directly after high-pressure liquid chromatography
(HPLC) and bioassay of the fraction containing
LTB4 , as determined from a synthetic standard; the
bioassay used aggregation of rat peritoneal neu-
trophils (sensitive to the picogram level) [6].The con-
centration of prostaglandin E2 (PGE2) in methanol-
extracted samples was determined by standard RIA
(sensitive to the picogram level) [7].
Statistical analysis of a single parameter between
groups was performed by the two-tailed Student's
t test.
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Results
Effect ofinhibitors ofthe arachidonic acid meta-
bolicpathway on inflammation. Intracisternal chal-
lenge with 108 cell equivalents of pneumococcal cell
wall (30 J.1g) rapidly induced the influx of PMNLs
and protein into the CSF. With a single dose of cell
walls, the CSF abnormalities were transient, with the
peak occurring at 7 hr postchallenge. Table 1 sum-
marizes the effect of inhibition of the arachidonic
acid pathway on the degree of inflammation after
an intracisternal challenge with lOS whole cellequiva-
lents of pneumococcal cell walls. In all cases, pro-
tein concentrations closely paralleled the number
of leukocytes. The lipoxygenase inhibitor nordi-
hydroguaiaretic acid did not significantly decrease
the CSF inflammatory response to cell walls. In con-
trast, the most-effective inhibitors of this response
were methylprednisolone and the cyclooxygenase in-
hibitor oxindanac (CGP 6258), which decreased the
number of leukocytes by >900/0. The cyclooxygenase
inhibitors diclofenac sodium and indomethacin also
reduced inflammation, but not as effectively as
methylprednisolone and oxindanac. The effects of
oxindanac and indomethacin were dose-dependent,
as shown in figure 1. As the doses of drug were de-
creased, the mean number of leukocytes present in
CSF increased toward control values.
Four rabbits were challenged with repeated in-
tracisternal doses of cell walls (200 J.1g) at 0, 5, 8,
and 24 hr. These repeated doses led to a greater and
more-sustained CSF leukocytosis than did single
doses (mean ± SD): 5,984 ± 1,566, 19,155 ± 3,875,
Table 1. Effect of cyclooxygenase and lipooxygenase inhibitors on CSF leukocytosis in rabbits after intracisternal
injection of 30 J.1g of pneumococcal cell walls.
CSF leukocytosis aftert
Compound Dose (rug/kg), route Time of administration* 5 hr 7 hr 24 hr
Control 677 ± 34 1,545 ± 90 870 ± 92
Methylprednisolone 30 im -1 50 ± 20 198 ± 30* 54 ± 20
Diclofenac sodium 5 iv -I, +2 110 ± 40 433 ± 210* 1,183 ± 150
Indomethacin 5 po§ -I, +2, +5 155 ± 60 300 ± 50* 320 ± 50
Nordihydroguaiaretic acid 5 po -I, +2, +5 1,093 ± 500 870 ± 240
Oxindanac 5 po -I, +2, +5 118 ± 57 59 ± 14* 500 ± 325
NOTE. po = perorally.
* In reference to time, in hours, of cell wall challenge dose.
t Mean of leukocytes/ul of CSF ± SD; value at 0 hr, 28 ± 14 cells/ul,
* Significant differences, P < 0.01 compared with control at 7 hr.
§ Administered by bolus injection through feeding tube.
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Figure 1. Inhibition of cell wall-induced leukocytosis in
CSF by inhibitors of arachidonate metabolism. Groups
of four rabbits were challenged intracisternally with 30 ug
of pneumococcal cell wall at time O. The leukocyte den-
sity appearing in CSF over 24 hr was determined in groups
receiving the following treatments at -1, 2, and 5 hr: no
drug (A), oxindanac po at 1.5mg/kg (0) or 5 mg/kg (e),
and indomethacin po at 1.5 mg/kg (D) or 5 mg/kg (.).
Values for oxindanac and indomethacin at 5 mg/kg at 3,
5, and 7 hr were statistically different from controls (P
< .01).
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and the number of leukocytes appearing in CSF af-
ter challenge with cell walls or live pneumococci.
Control preparations of whole pneumococci, cell
walls, or diclofenac sodium did not interfere with
the assay when tested directly (i.e., PGE2 values, <1
ng). Five hours after intracisternal challenge with cell
walls or living organisms, large increases in leuko-
cyte density (40-100-fold) and PGE2 concentration
(20-60-fold) occurred in CSF. In contrast, both the
leukocyte number and the PGE2 concentration re-
mained low when the cyclooxygenase inhibitor di-
clofenac sodium was administered in conjunction
with cell walls. No CSF samples tested showed any
detectable LTB4 bioactivity either in methanol-
extracted supernatants or after HPLC purification.
Thus, the activity of inhibitors of the cyclooxygenase
pathway in decreasing the magnitude of inflamma-
tion due to pneumococcal cell walls appeared to
correlate with low concentrations of PGE2 in CSF.
Effect of bacterial lysis on CSF inflammation.
Figure 2 demonstrates the effect of bacterial lysis
caused by ampicillin on the density of leukocytes in
CSF. At 30 min postinfusion, the peak ampicillin
concentration was reached (0.5 ug/ml) and exceeded
the MIC for strain SIll (0.01 ug/ml) by 50-fold. Bac-
terial killing ensued (decrease in cfu from 105 .8
cfu/ml before ampicillin to 102 cfu/ml 5 hr after
treatment with ampicillin). Bacterial lysis was
documented by the appearance of debris in CSF sam-
ples examined by light microscopy. As lysis pro-
gressed, an abrupt influx of PMNLs occurred, which
Table 2. Correlation between CSF leukocytosis and
concentration of PGE2 in CSF of rabbits challenged with
pneumococci or cell walls.
* Arithmetic mean of two challenges; SD ± <200 for leuko-
cyte number and ± <0.5 for PGEz concentration.
t ic = intracisternally.
t Significantly different from group treated with cell wall
alone, P < .01.
Mean values in CSF at
7 hr postchallenge*
and 12,540 ± 1,819 cells/ul in CSF samples taken
just before the wall challenges at 5, 8, and 24 hr,
respectively. Rabbits receiving repeated doses of cell
walls exhibited opisthotonus and paralysis, and two
of four animals died after the fourth dose.
When repeated intracisternal doses of cell walls
were adminstered to rabbits that were pretreated
orally with oxindanac 1hr before cell wall challenge,
the outcome was quite different. Leukocytosis was
less marked at 5, 8, and 24 hours: 5,330 ± 1,771,
9,755 ± 1,734, 5,515 ± 3,523 cells/ul, respectively
(P < .05 at 8 and 24 hr). Meningeal signs wereagain
seen in the animals, but none of the animals experi-
enced paralysis or died. Thus, oxindanac decreased
both the leukocyte number in CSF and the incidence
of severemeningeal signs such as paralysis and death.
Table 2 compares the CSF concentration of PGE2
Treatment conditions
Control (saline alone)
107 .5 Live pneumococci
Purified cell wall (30 ug)
Diclofenac sodium (iv) plus
30 ug of cell wall (ic)t
Leukocytosis
(cells/ul
of CSF)
40
4,570
1,545
PGE2
(ng/ml of CSF)
0.3
18.6
6.1
988
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Figure 2. Effect of cyclooxygenase inhibitor on CSF leu-
kocytosis after challenge with pneumococcal strain Sm.
Groups of five rabbits were challenged at time 0 with 103
pneumococci. The density of leukocytes in CSF was stud-
ied over 24 hr in groups treated as follows: no treatment
(_); ampicillin (. .), 50 mg/kg iv at the time in-
dicated by the open triangle; or ampicillin plus oxindanac
(. - - - .), 5 mg/kg po at the time indicated by the
closed triangles.
was absent in control animals not receiving ampicil-
lin (in which bacterial multiplication continued).
Thus, lysis and killing of pneumococci in the CSF
space was accompanied by a transient burst of in-
creased inflammation.
To determine if the anti-inflammatory effects of
cyclooxygenase inhibitors would modulate the in-
flammation associated with bacterial lysis in vivo,
we used oxindanac and ampicillin to treat animals
with established pneumococcal meningitis. As shown
in figure 2, the number of leukocytes appearing in
CSF after a dose of ampicillin was significantly lower
in the animals that also received oxindanac. Oxin-
danae did not alter the concentration of ampicillin
in the CSF (data not shown). Importantly, effective
bacterial killing occurred in oxindanac-treated
animals despite the lower density of CSF leukocytes;
a ~3 log killing occurred by 2 hr postampicillin treat-
ment in both the control and the oxindanac-treated
animals.
Discussion
The mortality from pneumococcal meningitis is
directly correlated with the amount of meningeal in-
flammation [1]. Two parameters used to quantitate
the inflammatory response are the density of CSF
leukocytes and the protein concentration, both of
which are increased during natural infection. Our
previous studies indicated that these abnormalities
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in CSF cytochemistry in experimental meningitis can
be generated by the interaction of host defenses with
the pneumococcal cell wall [2-4]. The current results
indicate that mortality is also associated with the per-
sistent presence of bacterial cell wall in the subarach-
noid space. Bacterial lysis in vivo and in vitro involves
the explosive release of cell wall degradation prod-
ucts into the surrounding environment. The results
reported here show that ampicillin-induced killing
of pneumococci in vivo, which entails such lysis, is
associated with a transient enhancement of the in-
flammatory response in the CSF space. This is con-
sistent with the fact that the major products of pneu-
mococcal autolysis are components of the cell wall
that are known to be highly inflammatory in this
meningitis model [2, 3].
Because enhancement of inflammation associated
with bacteriolysis may contribute to the poor out-
come of meningitis despite effective bacterial sterili-
zation, it was important to determine if the host
response to this transient inflammatory stimulus as-
sociated with chemotherapy could be modulated.
The present studies indicate that it is possible to re-
duce the inflammatory response in the CSF space
by inhibiting noncomplement-mediated host de-
fenses. Several inhibitors of the cylcooxygenase path-
way of arachidonic acid metabolism proved to be
highly effective in reducing the influx of leukocytes
and the elevation of protein concentration associated
with intracisternal inoculation with cell walls.
Methylprednisolone and oxindanac were particularly
effective, whereas indomethacin and diclofenac so-
dium were moderately effective. In contrast, inhibi-
tors of primarily the lipoxygenase pathway were
ineffective in preventing cell wall-induced inflam-
mation. When tested against the natural infection,
administering cyclooxygenase inhibitors in conjunc-
tion with 13-lactam antibiotics also markedly reduced
inflammation associated with release of inflamma-
tory bacterial products during bacterial lysis byam-
picillin.
Surprisingly, the arachidonic acid pathway that ap-
pears to playa significant role in generating inflam-
mation in the subarachnoid space of the rabbit is
not the lipooxygenase pathway, which generates the
powerful chemotaxin leukotriene B4 , but rather, the
cyclooxygenase pathway. This conclusion is based on
several lines of evidence. First, direct measurement
of arachidonic acid pathway metabolites suggested
a positive correlation between the concentration of
POE] and the number of leukocytes that appeared
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in CSF in response to either living pneumococci or
purified pneumococcal cell walls. Secondly, inhibi-
tors of the cyclooxygenase pathway reduced both
PGEz concentrations and CSF inflammation in re-
sponse to pneumococcal challenge. Prostaglandins
of the E series are known to induce fever in response
to endogenous pyrogen and to increase in concen-
tration in response to challenge of rabbits with Esch-
erichia coli or Shigella endotoxin [8, 9]. PGE:z are
also known to have direct effects on PMNLs, includ-
ing inhibition of chemotaxis in response to immune
complexes and inhibition of degranulation of leu-
kocytes activated by the chemotactic peptide formyl-
methionyl-Ieucyl-phenylalanine [10, 11]. These direct
effects would not, however, explain the correlation
of high concentrations of PGE:z with increased leu-
kocytosis in CSE Thus, our results do not distinguish
whether PGE:zcauses a previously undescribed en-
hancement of leukocyte chemotaxis in this particu-
lar site of infection or whether other cyclooxygenase
metabolites are the direct chemotaxins, and the PGE:z
response is correlated but secondary.
The approach we have taken to identify modes of
therapy that would decrease the currently stable mor-
bidity and mortality of meningitis has rested on the
thesis that decreased inflammation is a new goal to
be achieved in an era of chemotherapy in which bac-
terial killing is easily attained. Leukocytes in inflam-
matory exudates can most certainly contribute
directly to local tissue injury, particularly if host cell
membranes are coated with inflammatory bacterial
components (i.e., cell walls and lipid-linked cell wall
congeners). Cell walls can generate leukocytosis by
activating several host defenses [4, 12],and from the
present study, these components can even induce
death. The most-significant finding of this study is
that inhibiting the activity of one arm of the CSF
defense system, the cyclooxygenase pathway, appears
to reduce both the total CSF inflammatory mass and
to improve survival. Preliminary studies have con-
firmed and extended this association between cyclo-
oxygenase inhibitors and enhanced survival in other
instances of experimental meningeal inflammation
(0. Z., unpublished observations).
To further improve the outcome of bacterial
meningitis, we must identify the pathological lesions
associated with morbidity and mortality. Leukocyte-
induced damage is almost certainly not the only
source of destructive lesions. For instance, from the
studies of Tauber et al. [13, 14], CSF pressure is
known to correlate with bacterial density and with
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the concentration of cell walls in the CSF space.
Brain edema does not appear to show this correla-
tion. Yet, neither of these pathological lesions nor
even simple abnormalities in CSF chemistry are
directly dependent on leukocytes because all occur
in neutropenic animals [13-15]. Furthermore, our re-
cent studies indicate that death can be caused by in-
tracisternal inoculation of cell walls in both normal
and neutropenic animals (E. T., unpublished obser-
vations). Thus, the processes that generate leukocy-
tosis may also generate, in parallel, tissue damage
independent of leukocytes. In this regard, the abil-
ity of the arachidonic acid cascade to generate medi-
ators capable of altering vascular permeability, plate-
let function, etc. in addition to chemotaxins, may
be important. Thus, it may be the multiplicity of ef-
fects of inhibitors of the arachidonic acid pathway
that is critical to linking decreased leukocytosis, de-
creased tissue damage, and enhanced prognosis. The
combination of effects of individual inhibitors
varies, and the relative proportion of these effects
with the greatest benefit for outcome of disease re-
mains to be determined. Cyclooxygenase inhibitors
such as diclofenac sodium and oxindanac, however,
appear to be excellent candidates for improving out-
come of therapy when used in conjunction with ~­
lactam antibiotics to achieve bacterial killing dur-
ing pneumococcal meningitis.
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